Please use this identifier to cite or link to this item: http://scholarbank.nus.edu.sg/handle/10635/129755
Title: Beneficial effects of high-dose losartan in IgA nephritis
Authors: Woo, K.-T.
Chan, C.-M.
Tan, H.-K.
Choong, H.-L.
Foo, M.
Vathsala, A.
Lee, E.J.C. 
Tan, C.-C.
Lee, G.S.L.
Tan, S.H.
Lim, C.-H.
Chiang, G.S.C.
Fook-Chong, S.
Wong, S.K.S.
Keywords: ACEI
ARB
Glomerular filtration rate
Proteinuria
Renal failure
Treatment
Issue Date: Jun-2009
Citation: Woo, K.-T., Chan, C.-M., Tan, H.-K., Choong, H.-L., Foo, M., Vathsala, A., Lee, E.J.C., Tan, C.-C., Lee, G.S.L., Tan, S.H., Lim, C.-H., Chiang, G.S.C., Fook-Chong, S., Wong, S.K.S. (2009-06). Beneficial effects of high-dose losartan in IgA nephritis. Clinical Nephrology 71 (6) : 617-624. ScholarBank@NUS Repository.
Abstract: Aim: Several short-term studies have reported the efficacy of high-dose ARB in reducing proteinuria in patients with diabetic nephropathy. The benefits of long-term high-dose ARB losartan in IgA nephritis have not been explored. Method: This was a 6-year randomized trial in 207 patients with IgA nephritis comparing high-dose ARB (losartan 200 mg/day) with normal dose ARB (losartan 100 mg/day), normal dose ACEI (20 mg/day) and low-dose ACEI (10 mg/day). Multivariate ANOVA was used to test the effect of drug treatment on both eGFR and total urinary protein (TUP). Results: Comparing patients on high-dose ARB (n = 63) with those on normal dose ARB (n = 43), normal dose ACEI (n = 61) and low-dose ACEI (n = 40), patients on high Dose ARB had significantly higher eGFR (p < 0.0005) and lower proteinuria (p < 0.005) at the end of the study. The loss in eGFR was 0.7 ml/min/year for high-dose ARB compared to 3.2 - 3.5 ml/min/year for the other 3 groups (p = 0.0005). There were more patients on high-dose ARB with improvement in eGFR compared to other 3 groups (p < 0.001). Conclusion: Data from this study suggest that high-dose ARB therapy is more efficacious in reducing proteinuria and preserving renal function when compared with normal dose ARB and ACEI. In Year 5, patients on high-dose ARB had a gain in eGFR suggesting that there is possibility of recovery of renal function in these patients on long-term high-dose therapy. © 2009 Dustri-Verlag Dr. K. Feistle.
Source Title: Clinical Nephrology
URI: http://scholarbank.nus.edu.sg/handle/10635/129755
ISSN: 03010430
Appears in Collections:Staff Publications

Show full item record
Files in This Item:
There are no files associated with this item.

Page view(s)

17
checked on Sep 28, 2018

Google ScholarTM

Check


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.